tb/flu-01l
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2013 (NCT03017378)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Influenza virusImmunity, active
Influenza virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- tb/flu-01l
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03017378 | Phase 1 | Oct 1, 2013 | National Center for Tuberculosis Problems, Kazakhstan, Research Institute for Biological Safety Problems, Research Institute of Influenza, Russia |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Center for Tuberculosis Problems, Kazakhstan | Government | 1 | 0 | 1 | 2013 |
| Research Institute for Biological Safety Problems | Academic/Hospital | 1 | 1 | 1 | 2013 |
| Research Institute of Influenza, Russia | Academic/Hospital | 1 | 0 | 1 | 2013 |
3 organizations
Page 1 / 1